β-Lactamase inhibitors derived from single-domain antibody fragments elicited in the Camelidae

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 10, 2001, Pages 2807-2812

  Conrath, K E ^a   Lauwereys, M ^a   Galleni, M ^a   Matagne, A ^a   Frere J M ^a   Kinne, J ^a   Wyns, L ^a   Muyldermans, S ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BCII BETA LACTAMASE; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; BETA LACTAMASE TEM 1; IMMUNOGLOBULIN HEAVY CHAIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; BACILLUS CEREUS; CAMEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; IMMUNIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN;

AMINO ACID SEQUENCE; AMPICILLIN; ANIMALS; ANTIBODY SPECIFICITY; BACTERIAL PROTEINS; BETA-LACTAMASES; CAMELS; ESCHERICHIA COLI; IMMUNOGLOBULIN FRAGMENTS; MALE; MOLECULAR SEQUENCE DATA; PENICILLIN RESISTANCE; PENICILLINS; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0034812589     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.10.2807-2812.2001     Document Type: Article

References (30)

1. The beta-lactam antibiotics
2. The 3-D structure of a zinc metallo-β-lactamase from Bacillus cereus reveals a new type of protein fold
3. Development of new cloning vectors for the production of immunogenic outer membrane fusion proteins in Escherichia coli
4. Inactivation of antibiotics and the dissemination of resistance genes
5. One hypervariable loop of camel single-domain antibody sufficient for specific antigen recognition
6. Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme
7. Penicillin-sensitive enzymes in peptidoglycan biosynthesis
8. Beta-lactamases and bacterial resistance to antibiotics
9. Selection and identification of single-domain antibody fragments from camel heavy-chain antibodies
10. Serine beta-lactamases and penicillin-binding proteins
11. Naturally occurring antibodies devoid of light chains
12. Design of potent β-lactamase inhibitors by phage display of β-lactamase inhibitory protein
13. Extrachromosomal resistance in gram-negative organisms: The evolution of beta-lactamase
14. Systematic exploration of the antigen binding activity of synthetic peptides isolated from the variable regions of immunoglobulins
15. Potent enzyme inhibitors derived from dromedary heavy-chain antibodies
16. A loop mimetic inhibitor of the HCV-NS3 protease derived from a minibody
17. The beta-lactamase cycle: A tale of selective pressure and bacterial ingenuity
18. Mechanisms of bacterial resistance to antimicrobial agents
19. Single domain camel antibodies: Current status
20. Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains
21. HH and specific mechanisms enlarge the antigen-binding repertoire
22. Interaction between class B β-lactamases and suicide substrates of active-site serine β-lactamases
23. TEM β-lactamase mutants hydrolysing third-generation cephalosporins. A kinetic and molecular modelling analysis
24. Assembly of functional immunoglobulin Fv fragments in Escherichia coli
25. Structural and kinetic characterization of a β-lactamase-inhibitor protein
26. A potent new mode of beta-lactamase inhibition revealed by the 1.7 Å X-ray crystallographic structure of the TEM-1-BLIP complex
27. Camel single-domain antibody inhibits enzyme by mimicking carbohydrate substrate
28. D-peptides as immunogens and diagnostic reagents
29. Comparison of Ilama VH sequences from conventional and heavy chain antibodies